Shares of Addus Homecare Co. (NASDAQ:ADUS) hit a new 52-week high during trading on Wednesday after Sidoti raised their price target on the stock from $84.00 to $96.00. Sidoti currently has a buy rating on the stock. Addus Homecare traded as high as $84.99 and last traded at $82.71, with a volume of 35482 shares traded. The stock had previously closed at $80.90.
ADUS has been the subject of a number of other reports. BMO Capital Markets started coverage on shares of Addus Homecare in a report on Thursday, June 27th. They issued a “market perform” rating for the company. Zacks Investment Research raised shares of Addus Homecare from a “hold” rating to a “strong-buy” rating and set a $79.00 target price on the stock in a research note on Monday, May 13th. BidaskClub raised shares of Addus Homecare from a “hold” rating to a “buy” rating in a research note on Saturday, July 27th. Finally, Raymond James raised their target price on shares of Addus Homecare from $75.00 to $81.00 and gave the company an “outperform” rating in a research note on Thursday, June 13th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $81.11.
In other Addus Homecare news, CFO Brian Poff sold 814 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $67.96, for a total transaction of $55,319.44. Following the completion of the transaction, the chief financial officer now directly owns 18,241 shares of the company’s stock, valued at approximately $1,239,658.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Mark L. First sold 440,000 shares of the firm’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at $1,418,706.08. The disclosure for this sale can be found here. Insiders have sold a total of 460,814 shares of company stock worth $34,061,919 in the last ninety days. 20.10% of the stock is currently owned by insiders.
The stock has a market cap of $1.05 billion, a PE ratio of 48.92, a P/E/G ratio of 2.44 and a beta of -0.10. The stock’s 50-day moving average price is $77.18. The company has a quick ratio of 2.87, a current ratio of 2.87 and a debt-to-equity ratio of 0.10.
Addus Homecare (NASDAQ:ADUS) last released its earnings results on Monday, August 5th. The company reported $0.47 EPS for the quarter, hitting analysts’ consensus estimates of $0.47. Addus Homecare had a net margin of 3.20% and a return on equity of 8.95%. The business had revenue of $149.69 million for the quarter, compared to the consensus estimate of $146.66 million. On average, research analysts predict that Addus Homecare Co. will post 2.11 earnings per share for the current fiscal year.
About Addus Homecare (NASDAQ:ADUS)
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
See Also: Percentage Gainers
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.